Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab: A Nationwide Cohort Study
Crossref DOI link: https://doi.org/10.1007/s40123-021-00451-1
Published Online: 2022-01-22
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Billioti de Gage, Sophie http://orcid.org/0000-0003-4097-8495
Bertrand, Marion
Grimaldi, Sébastien
Zureik, Mahmoud
Text and Data Mining valid from 2022-01-22
Version of Record valid from 2022-01-22
Article History
Received: 23 November 2021
Accepted: 23 December 2021
First Online: 22 January 2022